ProfileGDS4095 / 218860_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 86% 86% 85% 85% 85% 85% 85% 85% 85% 83% 85% 85% 85% 86% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep19.8843686
GSM709769LY2 SRC1-siRNA tamoxifen treated rep39.7963286
GSM709765LY2 SRC1-siRNA untreated rep39.7214985
GSM709771LY2 SRC1-siRNA untreated rep19.6575885
GSM709772LY2 SRC1-siRNA untreated rep29.7305185
GSM709775LY2 SRC1-siRNA untreated rep49.747985
GSM709764LY2 control-siRNA tamoxifen treated rep29.6389785
GSM709766LY2 control-siRNA tamoxifen treated rep39.6787585
GSM709768LY2 control-siRNA tamoxifen treated rep19.7524685
GSM709777LY2 control-siRNA tamoxifen treated rep49.4120983
GSM709770LY2 control-siRNA untreated rep39.789585
GSM709773LY2 control-siRNA untreated rep19.6775785
GSM709774LY2 control-siRNA untreated rep29.7841985
GSM709776LY2 control-siRNA untreated rep49.9035786